Page 38 - MI-2-3
P. 38

Microbes & Immunity                                                    Correlation between VZV and cancer



               diagnosis after herpes zoster ophthalmicus: A  nationwide   109. Choi HG, Zehnder JL, Lee YK, Lim H, Kim M. Increased
               population-based study.  Ophthalmology. 2011;118(6):   risk of lymphoid malignancy in patients with herpes zoster:
               1076-1081.                                         A  longitudinal follow-up study using a national cohort.
                                                                  BMC Cancer. 2019;19(1):1148.
               doi: 10.1016/j.ophtha.2010.10.008
                                                                  doi: 10.1186/s12885-019-6349-y
            100. Han Y, Liu D, Li L. PD-1/PD-L1 pathway: Current researches
               in cancer. Am J Cancer Res. 2020;10(3):727-742.  110. Liu YC, Yang YH, Hsiao HH,  et al. Herpes zoster is
                                                                  associated with an increased risk of subsequent lymphoid
            101. Zhou H, Ye Z, Gao Z, et al. Construction of a pathological   malignancies  -  a nationwide population-based matched-
               model of skin lesions in acute herpes zoster virus   control study in Taiwan. BMC Cancer. 2012;12:503.
               infection and its molecular mechanism.  Mamm  Genome.
               2024;35(2):296-307.                                doi: 10.1186/1471-2407-12-503
               doi: 10.1007/s00335-024-10039-2                 111. Buntinx  F,  Bartholomeeusen  S,  Belmans  A,  et al.
                                                                  Association  between  recent  herpes  zoster  but  not  herpes
            102. Sorensen HT, Olsen JH, Jepsen P, Johnsen SP,     simplex infection and subsequent risk of malignancy in
               Schonheyder HC, Mellemkjaer L. The risk and prognosis of   women: A  retrospective cohort study.  Epidemiol Infect.
               cancer after hospitalisation for herpes zoster: A population-  2014;142(5):1008-1017.
               based follow-up study. Br J Cancer. 2004;91(7):1275-1279.
                                                                  doi: 10.1017/S0950268813001702
               doi: 10.1038/sj.bjc.6602120
                                                               112. Gershon M, Gershon A. Varicella-Zoster virus and the enteric
            103. Mahale P, Yanik EL, Engels EA. Herpes zoster and risk of   nervous system. J Infect Dis. 2018;218(Suppl 2):S113-S119.
               cancer in the elderly U.S. population.  Cancer Epidemiol
               Biomarkers Prev. 2016;25(1):28-35.                 doi: 10.1093/infdis/jiy407
                                                                                          rd
               doi: 10.1158/1055-9965.EPI-15-1033              113. Ragozzino MW, Melton LJ 3 , Kurland LT, Chu CP,
                                                                  Perry HO. Risk of cancer after herpes zoster: A population-
            104. Schmidt SA, Mor A, Schonheyder HC, Sorensen HT,   based study. N Engl J Med. 1982;307(7):393-397.
               Dekkers OM, Cronin-Fenton D. Herpes zoster as a marker
               of occult cancer: A  systematic review and meta-analysis.      doi: 10.1056/NEJM198208123070701
               J Infect. 2017;74(3):215-235.                   114. Leyh C, Roderburg C, Luedde T, Loosen SH, Kostev K.
               doi: 10.1016/j.jinf.2016.11.005                    Herpes zoster is not associated with subsequent
                                                                  gastrointestinal cancer: Data from over 200,000 outpatients
            105. Chiu HF, Chen BK, Yang CY. Herpes zoster and subsequent   in Germany.  J  Cancer Res Clin Oncol. 2023;149(19):
               risk  of  cancer:  A  population-based  study.  J  Epidemiol.   17115-17121.
               2013;23(3):205-210.
                                                                  doi: 10.1007/s00432-023-05432-4
               doi: 10.2188/jea.je20120155
                                                               115. Kim M, Han K, Yoo SA, Lee JH. Herpes zoster and
            106. Chen CH, Xirasagar S, Hung SH, Lin HC, Chen CS.   subsequent cancer risk: A  nationwide population-based
               Associations of head and neck cancers with herpes zoster in   cohort study in Korea. Dermatology. 2021;237(1):73-78.
               the preceding five years. Sci Rep. 2024;14(1):21541.
                                                                  doi: 10.1159/000505911
               doi: 10.1038/s41598-024-72893-z
                                                               116. Lee AW, Sou A, Patel M, Guzman S, Liu L. Early onset of
            107. Wang YP, Liu CJ, Hu YW, Chen TJ, Lin YT, Fung CP. Risk   nasopharyngeal cancer in Asian/Pacific Islander Americans
               of cancer among patients with herpes zoster infection:   revealed by age-specific analysis.  Ann Epidemiol. 2023;80:
               A population-based study. CMAJ. 2012;184(15):E804-E809.  25-29.
               doi: 10.1503/cmaj.120518                           doi: 10.1016/j.annepidem.2023.02.006
            108. Sim JH, Cho HS, Kim YD, et al. The association between   117. Zaha M, Hayashi I, Odashiro M, et al. Herpes zoster and
               herpes zoster and increased cancer risk: A  nationwide   malignancy. Masui. 1993;42(9):1343-1346.
               population-based matched control study.  Curr Oncol.   118. Yamamoto M, Mine H, Akazawa K, Maehara Y, Sugimachi K.
               2021;28(4):2720-2730.
                                                                  Gastrointestinal cancer and herpes zoster in adults.
               doi: 10.3390/curroncol28040237                     Hepatogastroenterology. 2003;50(52):1043-1046.











            Volume 2 Issue 3 (2025)                         30                               doi: 10.36922/mi.8320
   33   34   35   36   37   38   39   40   41   42   43